Stroke and Stroke Rehabilitation: Anticoagulant Therapy Prescribed for Atrial Fibrillation at Discharge
Percentage of patients aged 18 years and older with a diagnosis of ischemic stroke or transient ischemic attack (TIA) with documented permanent, persistent, or paroxysmal atrial fibrillation who were prescribed an anticoagulant at discharge
Atrial fibrillation is a significant modifiable risk factor for stroke. Preventive treatment lessens the chance of subsequent events and their attendant costs, morbidity, and mortality. The measure aligns clinicians’ practice with the goals of high value care by its focus on low-cost prevention of potentially expensive sequelae. We note that the measure would be improved by a clear enumeration of the medical reasons for withholding treatment. Reasons related to risk (for example, risk of fall) should require documentation of evaluation.